As shown in Figure 3A,C, the levels of procaspase-3, -8, and -9, as well as Bid and Bcl-2, decreased, while the levels of cleaved-PARP and Bax increased following sanggenol L treatment of prostate cancer RC-58T cells. This evidence concerns the gene PARP1 and prostate carcinoma.